Nutritional knowledge and use of the Mediterranean diet in people with type 2 diabetes
Official title: RELATIONSHIP Between ALimentary Knowledge and Adherence to the Mediterranean Diet in Patients With DIABete Mellito Type 2 Attending an Outpatient Service (REALDIAB)
Run by Casa di Cura Dott. Pederzoli · NCT07431359 · Data updated 2026-11-12
This study will test how much people with type 2 diabetes know about nutrition and how closely they follow the Mediterranean diet using questionnaires and a simple strength test.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Casa di Cura Dott. Pederzoli Academic / other |
| Locations | 1 site (Peschiera del Garda, Verona) |
| Status | Recruiting |
| Started | May 22, 2025 |
| Main results expected | May 19, 2026 |
| Study ends | May 19, 2026 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT07431359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with type 2 diabetes who are treated without insulin (on metformin, gliptins, gliflozins, incretin mimetics, pioglitazone, etc.) and able to give informed consent are ideal candidates.
✕Probably not a fit
People with type 1 diabetes, patients with type 2 diabetes treated with insulin, or those unwilling to complete questionnaires or attend clinic visits are unlikely to benefit from this observational protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, single-center study enrolling patients with type 2 diabetes attending an outpatient diabetology clinic. Participants complete questionnaires on nutrition knowledge and adherence to the Mediterranean diet while clinical parameters are collected from their records. A hand grip test is performed as a simple measure of muscle strength and functional status. Data will be analyzed to look for relationships between diet knowledge/adherence and clinical or functional measures.
Why it matters
Potential benefit: If successful, the results could identify gaps in knowledge and adherence that inform targeted education or dietary support to help improve glucose control and overall health.
How similar studies have gone: Previous research has shown benefits of the Mediterranean diet for glycemic control and cardiovascular risk in type 2 diabetes, and other observational work has linked dietary knowledge and adherence to clinical outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * T2DM in nutritional and/or pharmacological euglycemic treatment (metformin, gliptins, gliflozines, incretin mimetics, pioglitazone) * Signing of informed consent Exclusion Criteria: * Patient with Diabetes Mellitus type 1 * Patients with insulin T2DM treated
Where it's running
-
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Verona, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.